Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC

Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC

Background: Studies have shown that aggressive treatment of non-small cell lung cancer (NSCLC) with oligometastatic disease improves the overall survival (OS) compared to a palliative approach and some immunotherapy checkpoint inhibitors, such as anti-programmed cell death ligand 1 (PD-L1), anti-pro...

Full description

Bibliographic Details
Main Authors: Camille Gauvin, Vimal Krishnan, Imane Kaci, Danh Tran-Thanh, Karine Bédard, Roula Albadine, Charles Leduc, Louis Gaboury, Normand Blais, Mustapha Tehfe, Bertrand Routy, Marie Florescu
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Current Oncology
Subjects:
non-small cell lung cancer
oligometastatic
overall survival
PD-L1
aggressive treatment
immune checkpoint inhibitors
Online Access:https://www.mdpi.com/1718-7729/28/1/59

Similar Items

Similar Items